Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Short One Director for NYSE Rules

NEW YORK (GenomeWeb News) – The New York Stock Exchange has notified Bio-Rad Laboratories that it is not in compliance with exchange rules due to the resignation of a member of its board of directors and audit committee.

The NYSE said that the firm must have three independent directors of its audit committee to remain in compliance with market rules.

The recent resignation of Ruediger Naumann-Etienne left the company short one independent director for its audit committee. The firm has said that it is actively seeking a replacement for Naumann-Etienne and intends to regain compliance "as soon as practicable."

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.